Publication:
Paraoxonase 1 activity in endocrine diseases [Endokrin hastalıklarda paraoksonaz 1 enzim aktivitesi]

dc.contributor.authorsTarçin O., Yavuz D.G.
dc.date.accessioned2022-03-28T15:00:17Z
dc.date.accessioned2026-01-11T10:31:10Z
dc.date.available2022-03-28T15:00:17Z
dc.date.issued2011
dc.description.abstractParaoxonase is an esterase bound to high-density lipoproteins which by metabolizing lipid peroxides, prevents their accumulation on low-density lipoproteins. It also hydrolyzes various organophosphorus compounds. Considering the role of PON1 in hydrolyzing phospholipids and cholesteryl-ester hydroperoxides and thus protecting lipoproteins against oxidative modification, it can be concluded that PON1 may be an indicator of the risk of atherosclerosis/coronary artery disease development. Recent studies have also shown that PON activity was related to several disorders, including endocrine disorders as well. In this paper, we review the relation of PON1 activity with endocrine diseases like diabetes, thyroid dysfunction, osteoporosis, polycystic ovary syndrome (PCOS), obesity and dyslipidemia.
dc.identifier.issn13012193
dc.identifier.urihttps://hdl.handle.net/11424/256705
dc.language.isoeng
dc.publisherTurkiye Klinikleri
dc.relation.ispartofTurkish Journal of Endocrinology and Metabolism
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectAcromegaly
dc.subjectDiabetes
dc.subjectDyslipidemia
dc.subjectEndocrine disorders
dc.subjectObesity
dc.subjectParaoxonase 1
dc.subjectPCOS
dc.subjectPON1
dc.titleParaoxonase 1 activity in endocrine diseases [Endokrin hastalıklarda paraoksonaz 1 enzim aktivitesi]
dc.typereview
dspace.entity.typePublication
oaire.citation.endPage38
oaire.citation.issue2
oaire.citation.startPage33
oaire.citation.titleTurkish Journal of Endocrinology and Metabolism
oaire.citation.volume15

Files